Investigational Drug Details
| Drug ID: | D211 |
| Drug Name: | LPCN 1144 |
| Synonyms: | -- |
| Type: | Biological drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | AR activator |
| Therapeutic Category: | Metabolic disorder drug |
| Clinical Trial Progress: | Phase 2 on-going (NCT04685993) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0223 | NCT04134091 | Phase 2 | Completed | No Results Available | August 27, 2019 | February 25, 2022 | Details |
| L0275 | NCT04685993 | Phase 2 | Active, not recruiting | No Results Available | November 11, 2020 | February 14, 2022 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|